Grant of Long-Term Incentives
Summary by AI BETAClose X
4 June 2026
Kromek Group plc
("Kromek", the "Company" or the "Group")
Grant of Long-Term Incentives
Kromek (AIM: KMK), a global detection company delivering best-in-class solutions for the advanced imaging and CBRN detection markets, announces the grant of performance-based share awards under its Long-Term Incentive Plan (the "LTIP") to Executive Directors of the Company.
The Company has granted a total of 15,566,498 share awards under its LTIP in the form of options over ordinary shares of 1p each in the Company ("Ordinary Shares") that vest subject to the achievement of certain performance criteria (the "LTIP Awards") assessed over the three financial years ending 30 April 2028. The LTIP Awards have a nominal value exercise price of 1p per Ordinary Share. The LTIP Awards have been granted to Directors of the Company as follows:
|
Director |
No. of LTIP Awards |
|
Arnab Basu, CEO |
7,640,437 |
|
Claire Burgess, CFO |
2,458,256 |
|
Berry Beumer, COO |
5,467,805 |
The LTIP Awards will vest subject to the Company meeting a minimum relative total shareholder return ("RTSR") equal to the FTSE AIM All-Share Index Average Total Shareholder Return ("TSR") over the performance period. 25% of the LTIP Awards will vest on meeting this minimum threshold performance criteria, with vesting thereafter on a straight-line basis up to meeting a maximum performance target of a RTSR that is 30% greater than the FTSE AIM All-Share Index Average TSR.
Once vested, the LTIP Awards may be exercised at any time until the seventh anniversary of the vest date. The vest date is the last day of the performance period if, and to the extent that, the performance criteria has been met and subsequently ratified by the Board.
Accordingly, as at 3 June 2026, the Company had options and LTIPs outstanding over a total of 76,635,732 Ordinary Shares, representing 11.7% of the Company's issued share capital, and PDMRs/Directors had the following interest in the Company's issued share capital:
|
Director |
No. of Ordinary Shares |
Vested Options and LTIPs |
Unvested Options and LTIPs |
||
|
|
|
Options |
LTIPs |
Options |
LTIPs |
|
Arnab Basu |
3,198,750 |
8,912,308 |
7,500,000 |
375,000 |
13,557,332 |
|
Claire Burgess |
- |
- |
- |
2,500,000 |
1,229,128 |
|
Berry Beumer |
230,000 |
6,984,570 |
5,696,350 |
375,000 |
9,974,542 |
|
Rakesh Sharma |
1,310,208 |
59,033 |
- |
- |
- |
|
Christopher Wilks |
277,941 |
31,104 |
- |
- |
- |
|
Matt Boyle |
285,000 |
- |
- |
- |
- |
Enquiries
|
Kromek Group plc |
|
|
Arnab Basu, CEO Claire Burgess, CFO |
+44 (0)1740 626 060 |
|
|
|
|
Cavendish Capital Markets Limited (Nominated Adviser and Broker) |
|
|
Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance Andrew Burdis - ECM Michael Johnson - Sales |
+44 (0)20 7220 0500
|
|
|
|
|
Gracechurch Group (Financial PR) |
|
|
Harry Chathli/Claire Norbury |
+44 (0)20 4582 3500 |
Kromek Group plc
Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.
The advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defence and security market. Kromek's compact, handheld, high-performance radiation detectors, based on advanced scintillation and solid-state readout technology, are primarily used to protect critical infrastructure, events, personnel and urban environments from the threat of 'dirty bombs'.
The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a)
|
Name
|
Arnab Basu |
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
Chief Executive Officer |
||||
|
b)
|
Initial notification /Amendment
|
Initial notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
|
a)
|
Name
|
Kromek Group plc |
||||
|
b)
|
LEI
|
213800VLHYXGHEX5VQ48
|
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument |
Options over ordinary shares of 1 penny each |
||||
|
|
|
|||||
|
Identification code |
GB00BD7V5D43 |
|||||
|
|
|
|||||
|
b)
|
Nature of the transaction
|
Grant of options under Long-Term Incentive Plan |
||||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
||
|
|
|
1p |
7,640,437 |
|
||
|
|
|
|
|
|
||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A |
||||
|
|
|
|||||
|
e)
|
Date of the transaction
|
2 June 2026 |
||||
|
f)
|
Place of the transaction
|
Outside a trading venue |
||||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Claire Burgess |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Chief Financial Officer |
|||
|
b)
|
Initial notification /Amendment
|
Initial notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Kromek Group plc |
|||
|
b)
|
LEI
|
213800VLHYXGHEX5VQ48
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Options over ordinary shares of 1 penny each |
|||
|
|
|
||||
|
Identification code |
GB00BD7V5D43 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Grant of options under Long-Term Incentive Plan |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
1p |
2,458,256 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A |
|||
|
|
|
||||
|
e)
|
Date of the transaction
|
2 June 2026 |
|||
|
f)
|
Place of the transaction
|
Outside a trading venue |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Berry Beumer |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Chief Operating Officer and President of the Advanced Imaging Division |
|||
|
b)
|
Initial notification /Amendment
|
Initial notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Kromek Group plc |
|||
|
b)
|
LEI
|
213800VLHYXGHEX5VQ48
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Options over ordinary shares of 1 penny each |
|||
|
|
|
||||
|
Identification code |
GB00BD7V5D43 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Grant of options under Long-Term Incentive Plan |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
1p |
5,467,805 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A |
|||
|
|
|
||||
|
e)
|
Date of the transaction
|
2 June 2026 |
|||
|
f)
|
Place of the transaction
|
Outside a trading venue |
|||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 day ago Savannah Energy
- 1 day ago Buccaneer Energy PLC
- 1 day ago Savannah Energy
- 1 day ago Carclo
- 1 day ago Schroder Japan Growth Fund